Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Do nitrates differ?

¹Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo 14260.

British Journal of Clinical Pharmacology

|January 1, 1992

Summary

This summary is machine-generated.

Organic nitrates share a common mechanism but vary in potency and pharmacokinetics. Tolerance limits sustained-release nitrate duration to approximately 12 hours.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Domestic dog health worsens with socio-economic deprivation of their home communities.

Acta tropica·2014

Same author

Environmental variabilities and the distribution of octocorals and black corals in Hong Kong.

Marine pollution bulletin·2014

Same author

Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase.

AAPS pharmSci·2001

Same author

Relationship between pharmacokinetics and hemodynamic effects of inhaled isobutyl nitrite in conscious rats.

AAPS pharmSci·2001

Same author

Systemic biochemical effects of inhaled NO in rats: increased expressions of NOS III, nitrotyrosine-, and phosphotyrosine-immunoreactive proteins in liver and kidney tissues.

Nitric oxide : biology and chemistry·2001

Same author

Nitroglycerin-induced relaxation of anorectal smooth muscle: evidence for apparent lack of tolerance development in the anaesthetized rat.

British journal of pharmacology·2001

Same journal

Anticholinergic and central nervous system-active drug burdens and their associations with adverse in-hospital outcomes among older inpatients.

British journal of clinical pharmacology·2026

Same journal

N-acetylcysteine for non-paracetamol-induced acute liver failure in children: A systematic review and meta-analysis.

British journal of clinical pharmacology·2026

Same journal

Anti-seizure medications and DRESS in paediatric patients: A FAERS disproportionality and time-to-onset analysis.

British journal of clinical pharmacology·2026

Same journal

Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment.

British journal of clinical pharmacology·2026

Same journal

The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

British journal of clinical pharmacology·2026

Same journal

Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

British journal of clinical pharmacology·2026

See all related articles

Area of Science:

Pharmacology
Biochemistry
Drug Development

Background:

Organic nitrates are widely used vasodilators.
Understanding their pharmacokinetic and pharmacodynamic profiles is crucial for effective clinical use.

Purpose of the Study:

To elucidate the common mechanism of action for organic nitrates.
To compare the pharmacologic potency and pharmacokinetic properties of various organic nitrates.
To investigate the factors limiting the duration of action for sustained-release nitrate formulations.

Main Methods:

Comparative analysis of in vitro and in vivo data for different organic nitrates.
Pharmacokinetic profiling of immediate-release and sustained-release formulations.
Assessment of pharmacologic tolerance development.

Related Experiment Videos

Main Results:

All organic nitrates exhibit a unified biochemical and physiological mechanism.
Significant inter-drug variations in pharmacologic potency and pharmacokinetics were observed, with in vitro differences exceeding in vivo.
Pharmacokinetics dictate the duration of action for single doses, while tolerance limits sustained-release nitrates to ~12 hours.

Conclusions:

Organic nitrates share a common mechanism but differ in potency and pharmacokinetics.
Pharmacologic tolerance is a key limitation for sustained-release nitrate efficacy.
Nitrate formulations do not appear to differ in their adverse effect profiles.